
pmid: 16456323
Proliferations of Langerhans cells can be histologically divided into cytologically benign Langerhans cell proliferations, which include the clinical syndromes of Langerhans cell histiocytosis, and cytologically malignant Langerhans cell sarcoma. We report a Langerhans cell sarcoma in a 33-year-old male that arose on the posterior thigh with subsequent regional lymph node involvement. Conventional microscopic, immunohistochemical, and ultrastructural analysis confirmed Langerhans cell differentiation. Aberrant CD31 expression, similar to that described previously in Langerhans cell histiocytosis, was prominent in this tumor, possibly enhancing its migratory capabilities.
Adult, Male, Antibiotics, Antineoplastic, Skin Neoplasms, Remission Induction, Sarcoma, Disease-Free Survival, Histiocytosis, Langerhans-Cell, Doxorubicin, Langerhans Cells, Humans, Histiocytic Sarcoma, Ifosfamide, Lymph Nodes, Antineoplastic Agents, Alkylating
Adult, Male, Antibiotics, Antineoplastic, Skin Neoplasms, Remission Induction, Sarcoma, Disease-Free Survival, Histiocytosis, Langerhans-Cell, Doxorubicin, Langerhans Cells, Humans, Histiocytic Sarcoma, Ifosfamide, Lymph Nodes, Antineoplastic Agents, Alkylating
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 53 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
